MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B
出版年份 2018 全文链接
标题
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B
作者
关键词
Ovarian cancer, Chemoresistance, Cisplatin (cDDP), MiR-139, ATP7A, ATP7B
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 81, Issue 5, Pages 935-947
出版商
Springer Nature
发表日期
2018-03-28
DOI
10.1007/s00280-018-3548-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MicroRNA-mediated drug resistance in ovarian cancer
- (2017) Aynaz Mihanfar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
- (2017) Xiaolan Zhu et al. Oncotarget
- Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer
- (2017) Yangyang Hu et al. Oncotarget
- MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1
- (2016) Ping Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues
- (2016) Xiu Chen et al. GENE
- Suppressive Role of MicroRNA-148a in Cell Proliferation and Invasion in Ovarian Cancer Through Targeting Transforming Growth Factor-β-Induced 2
- (2016) Min Zhao et al. ONCOLOGY RESEARCH
- miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1
- (2016) Heyong Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets
- (2016) Si Sun et al. Oncotarget
- Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
- (2016) Shailendra Kumar Dhar Dwivedi et al. Oncotarget
- miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2
- (2016) Qingguo Li et al. Scientific Reports
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel
- (2015) He-da Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian Cancer
- (2015) Kimberly R. Kanigel Winner et al. CANCER RESEARCH
- The role of ABC transporters in ovarian cancer progression and chemoresistance
- (2015) M.P. Ween et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1
- (2015) ZHENGFANG WEN et al. Molecular Medicine Reports
- MicroRNA-148a inhibits the proliferation and promotes the paclitaxel-induced apoptosis of ovarian cancer cells by targeting PDIA3
- (2015) SHUZHEN ZHAO et al. Molecular Medicine Reports
- Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study
- (2015) Eric A. Benson et al. PLoS One
- miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM
- (2015) Sihai Yue et al. TUMOR BIOLOGY
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Regulation of Metastasis by microRNAs in Ovarian Cancer
- (2014) Yongchao Wang et al. Frontiers in Oncology
- microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin
- (2013) ZHONGXIAN WANG et al. Oncology Letters
- MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
- (2013) Young Tae Park et al. Journal of Ovarian Research
- Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
- (2012) Ahmed Y. Ali et al. Annals of the New York Academy of Sciences
- The diagnostic journey of ovarian cancer: A review of the literature and suggestions for practice
- (2012) Victoria Jayde et al. Contemporary Nurse
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Symptoms and diagnostic delay in ovarian cancer: A summary of the literature
- (2011) Victoria Jayde et al. Contemporary Nurse
- MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs
- (2011) Achim Aigner JOURNAL OF MOLECULAR MEDICINE-JMM
- Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
- (2011) Zhen-Ning Wang ONCOLOGY REPORTS
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started